REGENERON PHARMACEUTICALS

NDC#

EYLEA

Regeneron Pharmaceuticals, Inc.

aflibercept

LIBTAYO

Regeneron Pharmaceuticals, Inc.

cemiplimab-rwlc

Evkeeza

Regeneron Pharmaceuticals, Inc.

evinacumab

Evkeeza

Regeneron Pharmaceuticals, Inc.

evinacumab

VEOPOZ

Regeneron Pharmaceuticals, Inc.

Pozelimab

Inmazeb

Regeneron Pharmaceuticals, Inc.

atoltivimab, maftivimab, and odesivimab-ebgn

Inmazeb

Regeneron Pharmaceuticals, Inc.

atoltivimab, maftivimab, and odesivimab-ebgn

Praluent

Regeneron Pharmaceuticals, Inc.

alirocumab

Praluent

Regeneron Pharmaceuticals, Inc.

alirocumab

EYLEA HD

Regeneron Pharmaceuticals, Inc

aflibercept

EYLEA HD

Regeneron Pharmaceuticals, Inc

aflibercept

LYNOZYFIC

Regeneron Pharmaceuticals, Inc.

linvoseltamab-gcpt

LYNOZYFIC

Regeneron Pharmaceuticals, Inc.

linvoseltamab-gcpt

OTARMENI

Regeneron Pharmaceuticals, Inc.

lunsotogene parvec

Applications#

761355

REGENERON PHARMACEUTICALS

761339

REGENERON PHARMACEUTICALS

761181

REGENERON PHARMACEUTICALS

761169

REGENERON PHARMACEUTICALS

761097

REGENERON PHARMACEUTICALS

761055

REGENERON PHARMACEUTICALS

125387

REGENERON PHARMACEUTICALS

125249

REGENERON PHARMACEUTICALS